Zelalem Eshete

Array ( [id] => 11364026 [patent_doc_number] => 20170002006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'MACROCYCLES WITH HETROCYCLIC P2\' GROUPS AS FACTOR XIA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/115327 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 242391 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11471178 [patent_doc_number] => 20170057961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-02 [patent_title] => 'MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES' [patent_app_type] => utility [patent_app_number] => 15/115319 [patent_app_country] => US [patent_app_date] => 2015-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66773 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15115319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11218790 [patent_doc_number] => 09447117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Substituted 2-azabicycles and their use as orexin receptor modulators' [patent_app_type] => utility [patent_app_number] => 14/605387 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35362 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11809700 [patent_doc_number] => 09714258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-25 [patent_title] => 'Diaryl macrocycles as modulators of protein kinases' [patent_app_type] => utility [patent_app_number] => 15/113583 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 56833 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325717 [patent_doc_number] => 20150210720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'FURO-3-CARBOXAMIDE DERIVATIVES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/603043 [patent_app_country] => US [patent_app_date] => 2015-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88740 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14603043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414194 [patent_doc_number] => 20150299205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE' [patent_app_type] => utility [patent_app_number] => 14/601442 [patent_app_country] => US [patent_app_date] => 2015-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38366 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14601442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406592 [patent_doc_number] => 20150291601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE' [patent_app_type] => utility [patent_app_number] => 14/600214 [patent_app_country] => US [patent_app_date] => 2015-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41313 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14600214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12927757 [patent_doc_number] => 09828363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Fused pyrimidines as inhibitors of P97 complex [patent_app_type] => utility [patent_app_number] => 15/112659 [patent_app_country] => US [patent_app_date] => 2015-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38390 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 273 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263260 [patent_doc_number] => 09487547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'Cyclic phosphinate derivatives and method of preparing the same' [patent_app_type] => utility [patent_app_number] => 14/598143 [patent_app_country] => US [patent_app_date] => 2015-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12190 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14598143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10128113 [patent_doc_number] => 09161934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections' [patent_app_type] => utility [patent_app_number] => 14/595072 [patent_app_country] => US [patent_app_date] => 2015-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37398 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14595072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11901939 [patent_doc_number] => 09771364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => 'Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane' [patent_app_type] => utility [patent_app_number] => 15/108296 [patent_app_country] => US [patent_app_date] => 2014-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4264 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15108296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298749 [patent_doc_number] => 20150183749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => '5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE AND PROCESSES FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/584347 [patent_app_country] => US [patent_app_date] => 2014-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3028 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298751 [patent_doc_number] => 20150183750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => '5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE AND PROCESSES FOR THEIR PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/584368 [patent_app_country] => US [patent_app_date] => 2014-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3028 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14584368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11657241 [patent_doc_number] => 09670227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 14/576683 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 207326 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11211962 [patent_doc_number] => 09440991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Synthesis of an antiviral compound' [patent_app_type] => utility [patent_app_number] => 14/576143 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35378 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11121976 [patent_doc_number] => 20160318950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'FUSED BICYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN' [patent_app_type] => utility [patent_app_number] => 15/104351 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18298 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12489912 [patent_doc_number] => 09994581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-12 [patent_title] => Bromodomain inhibitors [patent_app_type] => utility [patent_app_number] => 15/103215 [patent_app_country] => US [patent_app_date] => 2014-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45367 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 391 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10214890 [patent_doc_number] => 20150099882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-09 [patent_title] => 'QUINOLINYL GLUCAGON RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 14/564263 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35095 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11129188 [patent_doc_number] => 20160326163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'BICYCLIC HETEROARYL INDOLE ANALOGUES USEFUL AS ROR GAMMA MODULATORS' [patent_app_type] => utility [patent_app_number] => 15/103658 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37341 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594447 [patent_doc_number] => 09315523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Cyclic dinucleosides' [patent_app_type] => utility [patent_app_number] => 14/562203 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12160 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562203 [rel_patent_id] =>[rel_patent_doc_number] =>)